4//SEC Filing
Benaim Ely 4
Accession 0001645113-22-000061
CIK 0001645113other
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 5:47 PM ET
Size
5.3 KB
Accession
0001645113-22-000061
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Benaim Ely
Chief Medical Officer
Transactions
- Award
Ordinary Shares
2022-07-05$59.08/sh+222$13,115→ 35,068 total
Footnotes (2)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2022 through June 30, 2022. This transaction is also exempt under Rule 16b-3(c).
- [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2022.
Documents
Issuer
NovoCure Ltd
CIK 0001645113
Entity typeother
Related Parties
1- filerCIK 0001632237
Filing Metadata
- Form type
- 4
- Filed
- Jul 6, 8:00 PM ET
- Accepted
- Jul 7, 5:47 PM ET
- Size
- 5.3 KB